stockrowCytek Biosciences, Inc. (CTKB) vs Pacific Biosciences of California, Inc. (PACB)
- Cytek Biosciences, Inc. CTKB 5.80 +7.41%
- Pacific Biosciences of California, Inc. PACB 2.28 −6.17%
Cytek Biosciences, Inc. and Pacific Biosciences of California, Inc. are both Medical Devices companies. Cytek Biosciences, Inc. and Pacific Biosciences of California, Inc. are of similar size ($755.3M and $701.9M). Cytek Biosciences, Inc. grew revenue faster over the last twelve months: 5.50% against 4.41%. Cytek Biosciences, Inc. has the higher net margin (−39.1% vs −81.3%) and the lower return on invested capital (−42.1% vs 0.00%). Across the 17 metrics below, Cytek Biosciences, Inc. leads on 10 and Pacific Biosciences of California, Inc. on 7.
Valuation
Profitability
| Metric | CTKB | PACB | Medical Devices median |
|---|---|---|---|
| Gross margin | 54.75% | 34.40% | 57.76% |
| Operating margin | (21.13%) | (81.27%) | (15.07%) |
| Net margin | (39.10%) | (81.31%) | (14.45%) |
| Free cash flow margin | (6.43%) | (84.85%) | (3.88%) |
| Return on equity | (23.20%) | 1,037.83% | (10.35%) |
| Return on assets | (17.26%) | (17.22%) | (17.26%) |
| Return on invested capital | (42.08%) | 0.00% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack